dc.creatorGRATIERI, Tais
dc.creatorGELFUSO, Guilherme Martins
dc.creatorROCHA, Eduardo Melani
dc.creatorSARMENTO, Victor Hugo
dc.creatorFREITAS, Osvaldo de
dc.creatorLOPEZ, Renata Fonseca Vianna
dc.date.accessioned2012-10-19T03:42:05Z
dc.date.accessioned2018-07-04T14:58:04Z
dc.date.available2012-10-19T03:42:05Z
dc.date.available2018-07-04T14:58:04Z
dc.date.created2012-10-19T03:42:05Z
dc.date.issued2010
dc.identifierEUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, v.75, n.2, p.186-193, 2010
dc.identifier0939-6411
dc.identifierhttp://producao.usp.br/handle/BDPI/20148
dc.identifier10.1016/j.ejpb.2010.02.011
dc.identifierhttp://dx.doi.org/10.1016/j.ejpb.2010.02.011
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1616932
dc.description.abstractThe aim of the present work was to obtain an ophthalmic delivery system with improved mechanical and mucoadhesive properties that could provide prolonged retention time for the treatment of ocular diseases. For this, an in situ forming gel comprised of the combination of a thermosetting polymer, poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) (PEO-PPO-PEO, poloxamer), with a mucoadhesive agent (chitosan) was developed. Different polymer ratios were evaluated by oscillatory rheology, texture and mucoadhesive profiles. Scintigraphy studies in humans were conduced to verify the retention time of the formulations developed. The results showed that chitosan improves the mechanical strength and texture properties of poloxamer formulations and also confers mucoadhesive properties in a concentration-dependent manner. After a 10-min instillation of the poloxamer/chitosan 16:1 formulation in human eyes, 50-60% of the gel was still in contact with the cornea surface, which represents a fourfold increased retention in comparison with a conventional solution. Therefore, the developed formulation presented adequate mechanical and sensorial properties and remained in contact with the eye surface for a prolonged time. In conclusion, the in situ forming gel comprised of poloxamer/chitosan is a promising tool for the topical treatment of ocular diseases. (C) 2010 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherELSEVIER SCIENCE BV
dc.relationEuropean Journal of Pharmaceutics and Biopharmaceutics
dc.rightsCopyright ELSEVIER SCIENCE BV
dc.rightsrestrictedAccess
dc.subjectThermosetting
dc.subjectPoloxamer
dc.subjectChitosan
dc.subjectOscillatory Rheology
dc.subjectMucoadhesion
dc.subjectHuman scintigraphy
dc.titleA poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución